Passiflore
Passiflore, licence 80040249: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Laboratoire Léo Désilets M.H.
- NPN or DIN-HM
- 80040249
- Status
- Active licence
- Licence date
- 22 February 2013
- Revision date
- 21 June 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Passiflora incarnata Source : Sommité (herbe) | 0.3 g | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | Not specified | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Utilisée traditionnellement en phytothérapie pour aider à dormir (dans les cas d'agitation ou d'insomnie liée au stress mental).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
La consommation en combinaison avec des breuvages alcoolisés ou tout autre médicament ou produit de santé naturel ayant des effets sédatifs est déconseillée. Consulter un praticien de soins de santé si les symptômes s'aggravent. Consulter un praticien de soins de santé si les symptômes persistent. Consulter un praticien de soins de santé si l'insomnie persiste au-delà de 3 semaines (insomnie chronique). Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez.
Source
Official Health Canada record, licence 80040249
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.